DRD
VRTX icon

Dennis R. Delaney’s Vertex Pharmaceuticals VRTX Stock Holding History

Dennis R. Delaney’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.83M Buy
11,733
+84
+0.7% +$37.2K 1.86% 24
2026
Q1 		$5.2M Buy
11,649
+4,680
+67% +$2.18M 1.84% 23
2025
Q4 		$3.16M Sell
6,969
-79
-1% -$34.1K 1.59% 24
2025
Q3 		$2.76M Sell
7,048
-295
-4% -$123K 1.38% 27
2025
Q2 		$3.27M Buy
7,343
+440
+6% +$203K 1.68% 24
2025
Q1 		$3.35M Buy
6,903
+433
+7% +$202K 1.82% 25
2024
Q4 		$2.61M Buy
6,470
+1,305
+25% +$605K 1.37% 29
2024
Q3 		$2.4M Buy
5,165
+2,300
+80% +$1.1M 1.24% 31
2024
Q2 		$1.34M Buy
2,865
+1,627
+131% +$706K 0.73% 34
2024
Q1 		$517K Buy
+1,238
New +$523K 0.28% 43

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dennis R. Delaney's VRTX Position: Q2 2026 in Review

Dennis R. Delaney increased its Vertex Pharmaceuticals (VRTX) stake by 0.72% in Q2 2026, buying an estimated $37.2K and bringing the position to 11,733 shares worth $5.83M. The position accounts for 1.86% of the portfolio, ranked #24.

Dennis R. Delaney first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Dennis R. Delaney held 11,733 shares of Vertex Pharmaceuticals worth $5.83M as of Q2 2026.
  • Dennis R. Delaney bought 84 Vertex Pharmaceuticals shares in Q2 2026, an estimated $37.2K.
  • Vertex Pharmaceuticals made up 1.86% of Dennis R. Delaney's portfolio in Q2 2026, its #24 holding.
  • Dennis R. Delaney first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Dennis R. Delaney's 13F filing for Q2 2026, filed 21 Aug 2026.